Safety and Efficacy of Brodalumab in Subjects With Axial Spondyloarthritis

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-003701-15

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the efficacy of brodalumab in ankylosing spondylitis (AS) compared to placebo, as measured by the proportion of AS subjects achieving an Assessment of SpondyloArthritis international Society (ASAS) 20 response at week 16.


Critère d'inclusion

  • Axial Spondyloarthritis